Aktis to collaborate with Eli Lilly on cancer therapies
By Thomson ReutersMay 21, 2024 | 6:38 AM
(Reuters) โ Aktis Oncology said on Tuesday it will collaborate with Eli Lilly to develop cancer therapies, making it eligible for milestone payments of up to $1.1 billion and royalties on sales.
(Reporting by Christy Santhosh; Editing by Krishna Chandra Eluri)
Comments